Search

(R5) Accelerated Approvals, Where Are We Now? A Follow Up on The Advantages and Pitfalls
(K2) GLP-1’s for Everything! The gift that keeps on giving… A review of the body of evidence and implications for managed care
(K3) Specialty Pharmaceuticals in Development
(L6) Understanding 340B Stakeholder Perspectives, Litigation Trends, and Reform Prospects
eLearning Day May 2025
Evolution of the Standards of Care in Atopic Dermatitis
Advancing Schizophrenia Management Strategies in the Patient Journey: Treatment Innovations, Adherence, and Health Outcomes
Hemgenix® (etranacogene dezaparvovec-drlb) at 4 Years: A Clinical and Economic Review
Optimizing Healthcare Outcomes: Clinical Advancements, Economic Impact of RYONCIL in Treating Pediatric SR-aGVHD
Advancing Equitable Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) Management Strategies in Managed Care
Charting a Better Path in Managing Multiple Myeloma: Overcoming Challenges and Driving Solutions
Mind Over Migraines: Disease Burden, Innovative Therapies, and Managed Care Trends in Treating Migraines
Encore Presentation: GLP-1s for Everything! A Review of the Body of Evidence and Implications for Managed Care
AMCP Market Insights: Webinar on ER+/HER2- Metastatic Breast Cancer Part 1
AMCP Market Insights: Webinar on ER+/HER2- Metastatic Breast Cancer Part 2
Unpacking the Trump Drug Pricing Executive Order
GLP-1’s for Everything! The gift that keeps on giving… A review of the body of evidence and implications for managed care
Health Care and the Judiciary

Pages